InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,646.00
(
0.25%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
83.95
(
0.47%
)
Bitcoin
62,635.68
(
2.37%
)
Post# of 2104
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Inoviorulez

Send PM Follow Ignore
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Inoviorulez

Re: bleu22 post# 1211

Wednesday, 03/08/2017 5:07:38 PM

Wednesday, March 08, 2017 5:07:38 PM

Post# of 2104
Me too I'm gonna keep adding until the phase 2b trial start is announced. If the stock continues to stay below $5 I will continue to accumulate shares. Because once Novartis takes the option to license Emricasan I don't see the stock staying in single digits for very long.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

Start posting your company's news
Only $200 per official company press release!